1. Home
  2. VIR vs WABC Comparison

VIR vs WABC Comparison

Compare VIR & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$9.76

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

N/A

Current Price

$59.36

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VIR
WABC
Founded
2016
1972
Country
United States
United States
Employees
N/A
627
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
VIR
WABC
Price
$9.76
$59.36
Analyst Decision
Strong Buy
Hold
Analyst Count
8
2
Target Price
$23.38
★ $65.00
AVG Volume (30 Days)
★ 1.8M
135.1K
Earning Date
11-04-2026
10-15-2026
Dividend Yield
N/A
★ 3.22%
EPS Growth
★ 17.49
N/A
EPS
N/A
★ 3.40
Revenue
★ $68,556,000.00
N/A
Revenue This Year
$305.75
N/A
Revenue Next Year
N/A
$1.81
P/E Ratio
★ N/A
$17.51
Revenue Growth
N/A
★ N/A
52 Week Low
$5.32
$46.23
52 Week High
$14.38
$63.61

Technical Indicators

Market Signals
Indicator
VIR
WABC
Relative Strength Index (RSI) 39.70 44.25
Support Level $8.23 $57.73
Resistance Level $10.32 $60.76
Average True Range (ATR) 0.80 1.39
MACD -0.06 -0.23
Stochastic Oscillator 1.39 8.92

Price Performance

Historical Comparison
VIR
WABC

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About WABC Westamerica Bancorporation

Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.

Share on Social Networks: